Global IVF Devices and Consumables Market

IVF Devices and Consumables Market Size, Share, Growth Analysis, By End User (Fertility Clinics, Hospitals, Clinical Research Institutes, Surgical Centers), By Product, By Technology, By Region -Industry Forecast 2025-2032


Report ID: SQMIG25AD2010 | Region: Global | Published Date: February, 2025
Pages: 189 | Tables: 91 | Figures: 71

IVF Devices and Consumables Market News

  • In October 2024, Dandi introduced IVF Care Kits designed to alleviate the discomfort of home-administered progesterone injections, a common step in fertility treatments. The kits include a heating pad to warm the injection oil, a cooling pad to numb the injection site, shot aids for accuracy, a supply belt, and a massage ball to prevent knots.
  • In August 2024, Australian company NeoGenix Biosciences unveiled SpermGuide, a palm-sized device that uses a complex array of microchannels to select the best sperm for fertilization. Unlike other conventional techniques, SpermGuide imitates the natural human female reproductive tract's process of selecting sperm. In a pilot study conducted by Melbourne IVF and IVF Australia, it was found that the gadget was significantly better at selecting high-quality sperm.
  • In July 2024, A Spanish biotech company called Oxolife also released what it calls promising preliminary findings on its fertility pill, OXO-001, a drug that directly impacts the inner layers of the uterus in order to better aid the implantation process during fertility treatment. The pill induced a 7% increase in live birth rates: the pregnancies were still ongoing for 46.3% of those treated with OXO-001 versus 35.7% of those on a placebo.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global IVF Devices and Consumables Market size was valued at USD 2.2 Billion in 2023 poised to grow from USD 2.61 Billion in 2024 to USD 10.14 Billion by 2032, growing at a CAGR of 18.5% in the forecast period (2025-2032).

The global IVF devices and consumables market is highly competitive, with key players focusing on technological advancements, product innovations, and strategic partnerships to maintain market share. CooperSurgical, Merck Group, Vitrolife, Ferring Pharmaceuticals, and Thermo Fisher Scientific are some of the major market players. Such companies are researching and developing more products, adding to their existing portfolios, and improving their supply chains to help them meet increasing demand for IVF treatments throughout the world. 'CooperSurgical (USA)', 'Vitrolife (Sweden)', 'Merck Group (Germany)', 'Ferring Pharmaceuticals (Switzerland)', 'Thermo Fisher Scientific (USA)', 'Genea Biomedx (Australia)', 'Irvine Scientific (USA)', 'Merck KGaA (Germany)', 'EMD Serono (USA/Switzerland)', 'Cook Medical (USA)', 'Smiths Medical (USA)', 'Labcorp Women’s Health (USA)', 'BioMérieux (France)', 'NOVA Biomedical (USA)', 'Ovum Biosciences (India)'

The rising prevalence of infertility, influenced by factors such as delayed pregnancies, lifestyle changes, and environmental factors, is a major driver for the IVF devices and consumables market. There is an increased number of people and couple seeking fertility treatment, and relatedly, there is a growing demand for higher IVF technologies and consumables.

Shift Towards Personalized IVF Treatments: The demand for personalized IVF treatments is significantly growing as advancements in genetic screening and artificial intelligence (AI) improve the customization of IVF procedures. Fertility clinics have increasingly embraced the use of technology that offers tailoring of treatment to an individual's genetic profile, which improves success rates. This way, it improves the outcome of a patient, limits the possibility of multiple cycles, and thus leads to cost effectiveness. Personalized treatments are increasingly driving the global IVF devices and consumables market trends, satisfying the increased need for effective fertility solutions.

North America holds the largest share in the global IVF devices and consumables market, leading the health care structure, fertility treatment awareness, and access to advanced IVF technologies. The United States is prominent in this region, holding wide ranges of fertility clinics, coupled with relentless investments in research and development for the advancement of the sector.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global IVF Devices and Consumables Market

Report ID: SQMIG25AD2010

$5,300
BUY NOW GET FREE SAMPLE